Bookbot

Bisphosphonates in Bone Disease, Fourth Edition

From the Laboratory to the Patient

Autor*innen

Parameter

  • 212 Seiten
  • 8 Lesestunden

Mehr zum Buch

This book is an essential handbook on bisphosphonates, the most widely used new class of drugs for osteoporosis therapy. It reviews basic physiology in addition to the indications and adverse reactions of these drugs. Bisphosphonates in Bone Disease, 4E, discusses the compounds' chemistry, mechanisms of action, and animal toxicology before presenting a clinical picture of the diseases treated by bisphosphonates. The book provides a table listing the trade names of the commercially available bisphosphonates, registered indications, and the available forms for various countries. The revised Fourth Edition contains approximately 50% new material, including information on all of the latest drugs. * The revised fourth edition contains approximately 50% new material * Includes information on all the latest drugs

Buchkauf

Bisphosphonates in Bone Disease, Fourth Edition, Herbert Fleisch

Sprache
Erscheinungsdatum
2000
Einband
(Paperback)
Wir benachrichtigen dich per E-Mail.

Lieferung

  • Gratis Versand ab 14,99 € in ganz Österreich! Mehr Infos.

Zahlungsmethoden

Keiner hat bisher bewertet.Abgeben

Titel
Bisphosphonates in Bone Disease, Fourth Edition
Untertitel
From the Laboratory to the Patient
Sprache
Englisch
Autor*innen
Herbert Fleisch
Erscheinungsdatum
2000
Einband
Paperback
Seitenzahl
212
ISBN10
0122603702
ISBN13
9780122603709
Reihe
Beschreibung
This book is an essential handbook on bisphosphonates, the most widely used new class of drugs for osteoporosis therapy. It reviews basic physiology in addition to the indications and adverse reactions of these drugs. Bisphosphonates in Bone Disease, 4E, discusses the compounds' chemistry, mechanisms of action, and animal toxicology before presenting a clinical picture of the diseases treated by bisphosphonates. The book provides a table listing the trade names of the commercially available bisphosphonates, registered indications, and the available forms for various countries. The revised Fourth Edition contains approximately 50% new material, including information on all of the latest drugs. * The revised fourth edition contains approximately 50% new material * Includes information on all the latest drugs